CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

PartnershipPositive
AI Analysis

Summary

Ligand Pharmaceuticals and AvenCell announced a financing partnership worth up to $47M to support the development of CAR-T therapies.

Importance:6/10
Sentiment:
0.60
partnershipfinancingCAR-Timmunotherapy
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 24, 2026 5:17 PM

Read Original